Thank You MBTS ConCom, Planning Board, for Cell Signaling Special Permit Approval

Posted
It’s hard to believe that it has been more than two and a half years since Town Meeting voted overwhelmingly to modify the zoning in the area around a forty-acre, former gravel quarry off Atwater Avenue.  This support from the Manchester community allowed Cell Signaling Technology to pursue the development of our new headquarters and to begin the local land-use approval process before the Planning Board and Conservation Commission.  
 
I am happy to share with you, if you do not already know, that the Planning Board recently voted to approve Cell Signaling’s application for a Special Permit.  We are proud of this milestone and we are excited to begin the construction of our new headquarters.  You can find out more about the project, including our land reclamation and sustainability efforts, at www.cstoldquarry.com.  Going forward, we will maintain this website to update the community on the progress of our construction efforts.
 
Throughout the numerous approval processes, our project received welcome support from many within the community, as well as from town officials and board members.  Together, we worked through the many facets of a complex plan to reclaim a difficult site with the goal of creating a world-class, sustainable research facility.  On behalf of the entire development team and my associates at Cell Signaling Technology, I want to thank the community of Manchester-by-the-Sea for its support and encouragement.   
 
Earlier this year, community leader and Planning Board Chair Ron Mastrogiacomo sadly passed away. I want to acknowledge Ron’s long service and his leadership.  I also want to thank new Chair, Sarah Creighton, and all the members of the Planning Board for working through a difficult situation seamlessly.   
 
All of us at Cell Signaling Technology are excited about joining the Manchester community and we look forward to actively contributing to this wonderful town that I proudly call home.
 
Thank you again,
 
Michael Comb, President, Chief Executive Officer
Cell Signaling Technology